[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Aldawsari et al., 2020 - Google Patents

Rapid microwave-assisted cisplatin-loaded solid lipid nanoparticles: synthesis, characterization and anticancer study

Aldawsari et al., 2020

View HTML
Document ID
16593566703301935445
Author
Aldawsari H
Singh S
Publication year
Publication venue
Nanomaterials

External Links

Snippet

Cisplatin is one of the most leading potent chemotherapy drugs prescribed for the treatment of most solid tumors. However, the induction of toxicities and the development of resistance restricts its applications. Efforts are made in the proposed study to control the delivery of …
Continue reading at www.mdpi.com (HTML) (other versions)

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51Nanocapsules; Nanoparticles
    • A61K9/5107Excipients; Inactive ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions; Emulsion preconcentrates; Micelles
    • A61K9/1075Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers

Similar Documents

Publication Publication Date Title
Aldawsari et al. Rapid microwave-assisted cisplatin-loaded solid lipid nanoparticles: synthesis, characterization and anticancer study
Lomis et al. Human serum albumin nanoparticles for use in cancer drug delivery: process optimization and in vitro characterization
Halayqa et al. PLGA biodegradable nanoparticles containing perphenazine or chlorpromazine hydrochloride: effect of formulation and release
Souto et al. Perillaldehyde 1, 2-epoxide loaded SLN-tailored mAb: Production, physicochemical characterization and in vitro cytotoxicity profile in MCF-7 cell lines
Niza et al. Trastuzumab-targeted biodegradable nanoparticles for enhanced delivery of dasatinib in HER2+ metastasic breast cancer
Go et al. Prpc aptamer conjugated–gold nanoparticles for targeted delivery of doxorubicin to colorectal cancer cells
Xu et al. pH and redox dual-responsive MSN-SS-CS as a drug delivery system in cancer therapy
Tao et al. Effects of particle hydrophobicity, surface charge, media pH value and complexation with human serum albumin on drug release behavior of mitoxantrone-loaded pullulan nanoparticles
Khan et al. FMSP-nanoparticles induced cell death on human breast adenocarcinoma cell line (MCF-7 cells): morphometric analysis
Aldawsari et al. Gum acacia functionalized colloidal gold nanoparticles of letrozole as biocompatible drug delivery carrier for treatment of breast cancer
Nasr et al. Bioavailability and antidiabetic activity of gliclazide-loaded cubosomal nanoparticles
Sun et al. Nanoformulation of a novel pyrano [2, 3-c] pyrazole heterocyclic compound AMDPC exhibits anti-cancer activity via blocking the cell cycle through a P53-independent pathway
Tazhbayev et al. Hydroxyurea-loaded albumin nanoparticles: Preparation, characterization, and in vitro studies
Zafar et al. Development and optimization of hybrid polymeric nanoparticles of apigenin: Physicochemical characterization, antioxidant activity and cytotoxicity evaluation
Mahmoud et al. Gold Nanocomplex strongly modulates the PI3K/Akt pathway and other pathways in MCF-7 breast cancer cell line
Shariare et al. Development of stable liposomal drug delivery system of thymoquinone and its in vitro anticancer studies using breast cancer and cervical cancer cell lines
Liu et al. Targeted co-delivery of gefitinib and rapamycin by aptamer-modified nanoparticles overcomes EGFR-TKI resistance in NSCLC via promoting autophagy
Fatemian et al. Cytotoxicity enhancement in breast cancer cells with carbonate apatite-facilitated intracellular delivery of anti-cancer drugs
Mohan et al. Optimising PLGA-PEG nanoparticle size and distribution for enhanced drug targeting to the inflamed intestinal barrier
Pramual et al. PLGA-lipid hybrid nanoparticles for overcoming paclitaxel tolerance in anoikis-resistant lung cancer cells
Shehata et al. Paclitaxel and myrrh oil combination therapy for enhancement of cytotoxicity against breast cancer; QbD approach
Carreón González et al. Gold nanoparticles as drug carriers: the role of silica and peg as surface coatings in optimizing drug loading
Sunoqrot et al. Vitamin E TPGS-poloxamer nanoparticles entrapping a novel PI3Kα inhibitor potentiate its activity against breast cancer cell lines
Kalyane et al. CD44-receptor targeted gold-doxorubicin nanocomposite for pulsatile chemo-photothermal therapy of triple-negative breast cancer cells
Boztepe et al. Design, synthesis, characterization, and evaluation of the anti-HT-29 colorectal cell line activity of novel 8-oxyquinolinate-platinum (II)-Loaded nanostructured lipid carriers targeted with riboflavin